These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24319648)

  • 21. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
    Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
    Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation.
    Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ
    Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease.
    Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS
    J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.
    Lin SL; Chang FC; Schrimpf C; Chen YT; Wu CF; Wu VC; Chiang WC; Kuhnert F; Kuo CJ; Chen YM; Wu KD; Tsai TJ; Duffield JS
    Am J Pathol; 2011 Feb; 178(2):911-23. PubMed ID: 21281822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
    López-Hernández FJ; López-Novoa JM
    Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
    Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
    Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diverse origins of the myofibroblast—implications for kidney fibrosis.
    Falke LL; Gholizadeh S; Goldschmeding R; Kok RJ; Nguyen TQ
    Nat Rev Nephrol; 2015 Apr; 11(4):233-44. PubMed ID: 25584804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis.
    Humphreys BD; Lin SL; Kobayashi A; Hudson TE; Nowlin BT; Bonventre JV; Valerius MT; McMahon AP; Duffield JS
    Am J Pathol; 2010 Jan; 176(1):85-97. PubMed ID: 20008127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression in chronic kidney disease.
    Eddy AA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of mesenchymal stem cells in kidney injury and fibrosis.
    Kuppe C; Kramann R
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):372-7. PubMed ID: 27191350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney fibrosis: from mechanisms to therapeutic medicines.
    Huang R; Fu P; Ma L
    Signal Transduct Target Ther; 2023 Mar; 8(1):129. PubMed ID: 36932062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis.
    Bijkerk R; Au YW; Stam W; Duijs JMGJ; Koudijs A; Lievers E; Rabelink TJ; van Zonneveld AJ
    Front Pharmacol; 2019; 10():215. PubMed ID: 30914951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction.
    Fligny C; Duffield JS
    Curr Opin Rheumatol; 2013 Jan; 25(1):78-86. PubMed ID: 23196325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracrine Wnt1 Drives Interstitial Fibrosis without Inflammation by Tubulointerstitial Cross-Talk.
    Maarouf OH; Aravamudhan A; Rangarajan D; Kusaba T; Zhang V; Welborn J; Gauvin D; Hou X; Kramann R; Humphreys BD
    J Am Soc Nephrol; 2016 Mar; 27(3):781-90. PubMed ID: 26204899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation.
    Sato Y; Yanagita M
    Inflamm Regen; 2017; 37():17. PubMed ID: 29259716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transforming growth factor-β and renal fibrosis].
    Meng XM; Lan HY
    Sheng Li Xue Bao; 2018 Dec; 70(6):612-622. PubMed ID: 30560270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney pericytes: roles in regeneration and fibrosis.
    Kramann R; Humphreys BD
    Semin Nephrol; 2014 Jul; 34(4):374-83. PubMed ID: 25217266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
    Shen M; Liu X; Zhang H; Guo SW
    Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.